Dipartimento di Scienze Farmacobiologiche, Università degli Studi Magna Graecia di Catanzaro, Complesso Ninì Barbieri, 88021 Roccelletta di Borgia, CZ, Italy.
ChemMedChem. 2010 Apr 6;5(4):575-83. doi: 10.1002/cmdc.200900541.
Molecular modeling studies carried out with experimental DNA models with the sequence d[AG(3)(T(2)AG(3))(3)] suggest that the introduction of a net positive charge onto the side chain of a series of fluorenone carboxamides can improve G-quadruplex binding. The terminal morpholino moiety was replaced with a novel N-methylmorpholinium cation starting from two 4-carboxamide compounds. A different substitution on the fluorenone ring was also investigated and submitted to the same quaternarization process. All compounds were analyzed for their DNA binding properties by competition dialysis methods. In vitro antiproliferative tests were carried out against two different tumor cell lines. Docking experiments were conducted by including all four known human repeat unit G-quadruplex DNA sequences (27 experimentally determined conformations) against the most active fluorenone derivatives. The results of theoretical, biophysical, and in vitro experiments indicate two novel derivatives as lead compounds for the development of a new generation of G-quadruplex ligands with greater potency and selectivity.
分子建模研究采用具有序列 d[AG(3)(T(2)AG(3))(3)] 的实验 DNA 模型进行,表明在一系列芴酮羧酰胺的侧链上引入净正电荷可以提高 G-四链体结合。从两个 4-羧酰胺化合物开始,用新型 N-甲基吗啉鎓阳离子取代末端吗啉基部分。还研究了芴酮环上的不同取代基,并进行了相同的季铵化处理。通过竞争透析方法分析所有化合物的 DNA 结合特性。针对两种不同的肿瘤细胞系进行了体外增殖抑制试验。对接实验通过包含所有四个已知的人类重复单元 G-四链体 DNA 序列(27 个实验确定的构象)对最活跃的芴酮衍生物进行了研究。理论、生物物理和体外实验的结果表明,有两个新型衍生物作为新一代具有更高效力和选择性的 G-四链体配体的先导化合物。